Laboratory Services Contracts – West of England

Laboratory Services Contracts – West of England

West of England Pathology Network – Provision of Agreements for Laboratory Services. 8 Lots.

United Kingdom-Bristol: Pathology services

2019/S 030-067182

Contract notice

Services

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

North Bristol NHS Trust
Southmead Road, Bristol
Bristol
BS10 5NB
United Kingdom
Contact person: Martin Strawson
Telephone: +44 1173420815
E-mail: martin.strawson@UHBristol.nhs.uk
NUTS code: UKK11
Internet address(es):Main address: https://www.nbt.nhs.uk/

I.1)Name and addresses

University Hospitals Bristol NHS Foundation Trust
Marlborough Street
Bristol
BS1 3NU
United Kingdom
Contact person: Martin Strawson
Telephone: +44 1173420815
E-mail: martin.strawson@UHBristol.nhs.uk
NUTS code: UKK11
Internet address(es):Main address: http://www.uhbristol.nhs.uk/

I.1)Name and addresses

Weston Area Health NHS Trust
Grange Road, Uphill, Weston-Super-Mare
Weston Super Mare
BS23 4TQ
United Kingdom
Contact person: Martin Strawson
Telephone: +44 1173420815
E-mail: martin.strawson@UHBristol.nhs.uk
NUTS code: UKK12
Internet address(es):Main address: www.waht.nhs.uk

I.1)Name and addresses

Gloucestershire Hospitals NHS Foundation Trust
Great Western Road
Gloucester
GL1 3NN
United Kingdom
Contact person: Martin Strawson
Telephone: +44 1173420815
E-mail: martin.strawson@UHBristol.nhs.uk
NUTS code: UKK13
Internet address(es):Main address: www.gloshospitals.nhs.uk

I.1)Name and addresses

The Secretary of State for Health acting by Public Health England — South West Laboratory
Southmead Road, Bristol
Bristol
BS10 5NB
United Kingdom
Contact person: Martin Strawson
Telephone: +44 1173420815
E-mail: martin.strawson@UHBristol.nhs.uk
NUTS code: UKK11

I.1)Name and addresses

Royal United Hospitals Bath NHS Foundation Trust
Combe Park
Bath
BA1 3NG
United Kingdom
Contact person: Martin Strawson
Telephone: +44 1173420815
E-mail: martin.strawson@UHBristol.nhs.uk
NUTS code: UKK12
Internet address(es):Main address: http://www.ruh.nhs.uk/

I.2)Information about joint procurement

The contract involves joint procurement

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://uk.eu-supply.com/login.asp?B=NHSSW
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://uk.eu-supply.com/login.asp?B=NHSSW
Tenders or requests to participate must be submitted to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at: https://uk.eu-supply.com/login.asp?B=NHSSW

I.4)Type of the contracting authority

Other type: NHS trust

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

West of England Pathology Network — Provision of Agreements for Laboratory Services

Reference number: BWPCCL0992

II.1.2)Main CPV code

85111800 – LA33 – RA06

II.1.3)Type of contract

Services

II.1.4)Short description:

For the purpose of this Procurement, the five NHS Trusts named in this notice plus PHE who are at this stage, committed to Lots 1 and 6 and an interested party in other lots and will confirm their commitment and contracting intentions following the Invitation to Submit Detailed Solutions stage based on the financial and commercial benefits of the proposed solutions.

Bristol and Weston NHS Purchasing Consortium (BWPC) is an agent of the Partner Organisations, acting on their behalf solely to carry out the procurement of the Laboratory Services. All decisions regarding the award of the Contracts will be made by the Partner Organisations.

Scope of the Services includes the provision and maintenance of pathology equipment as well as the provision of all associated consumables; reagents, collection devices and quality control material necessary for the delivery of the activity and scope of services covered under this tender

https://uk.eu-supply.com/login.asp?B=NHSSW – ref RFT34355

II.1.5)Estimated total value

Value excluding VAT: 292 215 000.00 GBP

II.1.6)Information about lots

This contract is divided into lots: yes
Tenders may be submitted for all lots
The contracting authority reserves the right to award contracts combining the following lots or groups of lots:

The Procurement is divided into Lots (1 to 8). Bidders are able to bid for single or multiple Lots. The successful provider for Lot 1 or Lot 3 (which is the option to combine Lots 1 and 2) is expected to prime the provision of the Laboratory Services under all of the Lots. Therefore, the successful providers under Lots 2 to 8 shall become mandatory Sub-Contractors to the MSP.

II.2)Description

II.2.1)Title:

Blood Sciences including overall Managed Services Provision (with Automated Serology)

Lot No: 1

II.2.2)Additional CPV code(s)

33696500
42931100
51430000
71900000
33696200
33696100
38434520
38434000
38434560
38434570
38434580

II.2.3)Place of performance

NUTS code: UKK11
NUTS code: UKK12
NUTS code: UKK13
Main site or place of performance:

All relevant pathology laboratories within the Network — as per tender documents.

II.2.4)Description of the procurement:

5 NHS acute trusts and Public Health England (South West Laboratory) are seeking to procure the following:

Laboratory Services includes the provision and maintenance of pathology equipment as well as the provision of all associated consumables; reagents, collection devices and quality control material necessary for the delivery of the activity and scope of services covered under this tender. There 8 lots covering the following (full details of current scope and future scope are described in the tender documents):-

Lot 1 — Blood sciences including overall MSC Provision (with automated serology):

— front and back end automation,

— off track sample management,

— automated coagulation,

— flow cytometry,

— automated biochemistry and immunoassay,

— automated serology,

— haemoglobinopathy screening,

— HbA1c,

— protein electrophoresis,

— autoimmune testing,

— allergy,

— newborn screening,

— amino acids.

Collection Devices (including Urine Tubes removed from Lot 1c)

Lot 2 – Automated haematology.

Lot 3 – Combined Lot 1 and 2 option.

Lot 4 – Automated blood grouping/antibody screening.

Lot 5 – Infection Sciences:

— automated urine screening,

— automated blood culture,

— EIA faeces,

— pre poured media.

Lot 6 – Molecular:

— automated molecular virology,

— specialised molecular.

Lot 7 — Histopathology/neuropathology – including Non Gynae Cytology (1 OBS):

— Slide and Cassette identification and labelling,

— Tissue Processing,

— Tissue Embedding,

— Microtomy,

— Staining – routine and special,

— Coverslipping,

— Cryotomy,

— Immunohistochemistry,

— Digital Microscopy,

— Sample tracking.

Lot 8 — Point of Care Testing:

— Blood Glucose and Ketone Monitoring.

(temperature monitoring at GHFT could be included in future scope for GHFT).

The Organisations require a solution that builds upon the benefits and efficiencies garnered under existing arrangements, whilst creating a recognised exemplar model for the delivery of Laboratory Services. To achieve this it will need to continue to improve and develop through the term of the Contracts, benefit from ongoing access to new technologies, drive excellence in performance and act as a key facilitator and enabler to future strategic developments.

The objectives of the Procurement are to:

— enable the Organisations to deliver high quality, cost effective and customer focused pathology services and to deliver improved health care in the health economy,

— be focused on the needs of each Organisation’s service users,

— deliver significant financial benefits to all Organisations through cost reduction,

— improve quality and performance through the application and embedding of continuous improvement methodologies,

— replace existing equipment with new equipment and realise the operational benefits of new technology,

— facilitate delivery of a recognised exemplar pathology service in the United Kingdom,

— reduce burden on each Organisation’s capital expenditure,

— explore value added services,

— facilitate the delivery of NHSI agenda in relation to the Model Hospital.

A joint contract management structure between the Organisations will be established post contract award to ensure these objectives are realised through a ‘system wide approach’.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 143 850 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/07/2021
End: 30/06/2036
This contract is subject to renewal: no

II.2.9)Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 5
Objective criteria for choosing the limited number of candidates:

Please see tender documents for shortlisting methodology and detailed award criteria. It is envisaged 5 bidders will progress to ISOS stage.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description

II.2.1)Title:

Automated Haematology

Lot No: 2

II.2.2)Additional CPV code(s)

38434570
33696500
71900000

II.2.3)Place of performance

NUTS code: UKK11
NUTS code: UKK12
NUTS code: UKK13
Main site or place of performance:

All relevant pathology laboratories within the Network — as per tender documents.

II.2.4)Description of the procurement:

See description for Lot 1.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 18 975 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/07/2021
End: 30/06/2036
This contract is subject to renewal: no

II.2.9)Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 5
Objective criteria for choosing the limited number of candidates:

Please see tender documents for shortlisting methodology and detailed award criteria. It is envisaged 5 bidders will progress to ISOS stage.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description

II.2.1)Title:

Combined Lot 1 and 2 Option

Lot No: 3

II.2.2)Additional CPV code(s)

33696500
71900000
38434000
38434520
38434560
38434570
38434580
85111810

II.2.3)Place of performance

NUTS code: UKK11
NUTS code: UKK12
NUTS code: UKK13
Main site or place of performance:

All relevant pathology laboratories within the Network — as per tender documents.

II.2.4)Description of the procurement:

As per description within Lot 1.

However it is important to note, that Lot 3 is a combined lot to allow for a joint submission Lot 1 and 2. It wont automatically be assumed that if a bidder submits a lot 1 submission and a lot 2 submission that these will be aggregated. This will not be the case and a formal Lot 3 submission will also need to be submitted to in order to demonstrate the benefits of level of integration and amalgamation of supply chains. Please refer to tender documents for further information.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 162 825 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/07/2021
End: 30/06/2036
This contract is subject to renewal: no

II.2.9)Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 5
Objective criteria for choosing the limited number of candidates:

Please see tender documents for shortlisting methodology and detailed award criteria. It is envisaged 5 bidders will progress to ISOS stage.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description

II.2.1)Title:

Automated Blood Grouping/Antibody Screening

Lot No: 4

II.2.2)Additional CPV code(s)

33194210
33194220
38434520
43411000
45252123
71900000

II.2.3)Place of performance

NUTS code: UKK11
NUTS code: UKK12
NUTS code: UKK13
Main site or place of performance:

All relevant pathology laboratories within the Network — as per tender documents.

II.2.4)Description of the procurement:

As per description in Lot 1.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 7 305 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/07/2021
End: 30/06/2036
This contract is subject to renewal: no

II.2.9)Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 4
Objective criteria for choosing the limited number of candidates:

Please see tender documents for shortlisting methodology and detailed award criteria. It is envisaged 4 bidders will progress to ISOS stage.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description

II.2.1)Title:

Infection Sciences

Lot No: 5

II.2.2)Additional CPV code(s)

33696200
38434550
85111810
38434000
38434520
33698100
33696500
71900000

II.2.3)Place of performance

NUTS code: UKK11
NUTS code: UKK12
NUTS code: UKK13
Main site or place of performance:

All relevant pathology laboratories within the Network — as per tender documents.

II.2.4)Description of the procurement:

As per description within Lot 1

Potential future scope:

— bacteriology,

— antimicrobial lab at — NBT,

— enterics molecular,

— automated urine screening,

— automated blood culture.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 25 485 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/07/2021
End: 30/06/2036
This contract is subject to renewal: no

II.2.9)Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 3
Objective criteria for choosing the limited number of candidates:

Please see tender documents for shortlisting methodology and detailed award criteria. It is envisaged 3 bidders will progress to ISOS stage.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description

II.2.1)Title:

Molecular

Lot No: 6

II.2.2)Additional CPV code(s)

38512200
71900000
33694000

II.2.3)Place of performance

NUTS code: UKK11
NUTS code: UKK12
NUTS code: UKK13
Main site or place of performance:

All relevant pathology laboratories within the Network — as per tender documents.

II.2.4)Description of the procurement:

As per description within Lot 1.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 48 780 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/07/2021
End: 30/06/2036
This contract is subject to renewal: no

II.2.9)Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 4
Objective criteria for choosing the limited number of candidates:

Please see tender documents for shortlisting methodology and detailed award criteria. It is envisaged 4 bidders will progress to ISOS stage.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description

II.2.1)Title:

Histopathology/Neuropathology (Including Non Gynae Cytology)

Lot No: 7

II.2.2)Additional CPV code(s)

71900000
38434000

II.2.3)Place of performance

NUTS code: UKK11
NUTS code: UKK12
NUTS code: UKK13
Main site or place of performance:

All relevant pathology laboratories within the Network — as per tender documents.

II.2.4)Description of the procurement:

As per description in Lot 1.

Cytology HPV at NBT may be included within future scope subject to regional procurement tender outcomes for HPV.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 31 170 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/07/2021
End: 30/06/2036
This contract is subject to renewal: no

II.2.9)Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 3
Objective criteria for choosing the limited number of candidates:

Please see tender documents for shortlisting methodology and detailed award criteria. It is envisaged 3 bidders will progress to ISOS stage.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description

II.2.1)Title:

Point of Care Testing

Lot No: 8

II.2.2)Additional CPV code(s)

38434520
38434550
85111810
33696200
33696100

II.2.3)Place of performance

NUTS code: UKK11
NUTS code: UKK12
NUTS code: UKK13
Main site or place of performance:

All relevant pathology laboratories within the Network — as per tender documents.

II.2.4)Description of the procurement:

As per description within Lot 1.

Other PoCT eg HbA1c, Hb etc may included in future scope at GHFT.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 16 650 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/07/2021
End: 30/06/2036
This contract is subject to renewal: no

II.2.9)Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 4
Objective criteria for choosing the limited number of candidates:

Please see tender documents for shortlisting methodology and detailed award criteria. It is envisaged 4 bidders will progress to ISOS stage.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

III.1.2)Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3)Technical and professional ability

Selection criteria as stated in the procurement documents
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.1)Information about a particular profession
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Competitive dialogue
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information

IV.2.1)Previous publication concerning this procedure

Notice number in the OJ S: 2018/S 223-510319

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 25/03/2019
Local time: 12:00

IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

Date: 10/05/2019

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 01/07/2021
IV.2.7)Conditions for opening of tenders

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: yes
Estimated timing for further notices to be published:

This contract will run from July 2021 to 2036. There is every likelihood this will be a recurrent procurement thereafter.

VI.2)Information about electronic workflows
VI.3)Additional information:
VI.4)Procedures for review

VI.4.1)Review body

Bristol and Weston Purchasing Consortium
Level 3, Whitefriars, Lewins Mead
Bristol
BS1 2NT
United Kingdom
VI.4.2)Body responsible for mediation procedures

VI.4.3)Review procedure

Precise information on deadline(s) for review procedures:

BWPC will incorporate a minimum 10 calendar day Standstill Period following electronic notification to unsuccessful applicants of the award decision. An economic operator that suffers, or risks suffering, loss or damage attributable to a breach of duty under the Public Contracts Regulations 2015 (SI 2015 No 102) may bring proceedings in the High Court (England, Wales and Northern Ireland). Any such action must be brought promptly.

VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

07/02/2019